Valeant's (VRX) hostile takeover bid for Cephalon (CEPH) is certainly living up to the "hostile" part: A slideshow it made for investors basically says, "You suck, Cephalon. Hand over your shares by ...

Employees at small and midsize pharma companies observing Valeant (VRX)'s attempted hostile takeover of Cephalon (CEPH) -- and the dismembering of the company that will surely follow -- should remind ...

FRAZER, Pa., Aug. 10 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) announced today that it has completed its previously announced acquisition of all of the ...

Cephalon, Inc., (Nasdaq: CEPH) today announced Frank Baldino, Jr., Ph.D., the company's Chairman and Chief Executive Officer, will take a temporary medical leave of ...

The FTC filed a complaint against Cephalon in U.S. District Court for the District of Columbia on February 12, 2008. [3] At the time, Cephalon marketed a brand prescription drug called Provigil ®, ...

--Quarterly Sales of $712 Million Increased 32 Percent --Quarterly Basic Adjusted EPS of $2.20 Increased 41 Percent --Ex-US Sales Exceed 25 Percent of Worldwide Sales for the First Time FRAZER, Pa., ...

The Cephalon European headquarters and pre-clinical development center are located in Maisons-Alfort, France, just outside of Paris. Key business units are located in England, Ireland, France, Germany ...

SAN ANTONIO, May 4 /PRNewswire-FirstCall/ -- Results of a Phase 3 clinical trial demonstrate positive results with a fentanyl effervescent buccal tablet (FEBT) in all ...

FRAZER, Pa., Jan. 28 /PRNewswire-FirstCall/ -- Cephalon, Inc., (NASDAQ: CEPH) today announced the promotion of three executives, Kevin Buchi, Wilco Groenhuysen and ...

Powerful cancer pain drugs were given to patients with other conditions who cannot tolerate them. A program to curb the practice was run by companies that sell the drugs. By Emily Baumgaertner The ...

NEW YORK, March 29 (Reuters) - Canadian drugmaker Valeant Pharmaceuticals International said it made an unsolicited $5.7 billion bid to buy Cephalon Inc and plans to make its case directly to Cephalon ...

NEW YORK, Sept 24 (Reuters) - U.S. regulators will review Cephalon Inc's Nuvigil sleep disorder drug on a priority basis for an additional use of treating excessive sleepiness tied to jet lag, the ...